We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$157M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$112M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$109M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$73.1M
5
T icon
AT&T
T
+$64.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$134M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$73.7M
3
DD icon
DuPont de Nemours
DD
+$64.2M
4
CCI icon
Crown Castle
CCI
+$45.2M
5
CSCO icon
Cisco
CSCO
+$42M

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RWK icon
1951
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.34B
$1.49M ﹤0.01%
24,521
-709
-3% -$42.5K
CCJ icon
1952
Cameco
CCJ
$42.4B
$1.49M ﹤0.01%
139,185
-79,510
-36% -$856K
ISBC
1953
DELISTED
Investors Bancorp, Inc.
ISBC
$1.49M ﹤0.01%
133,437
-4,423
-3% -$50.1K
LNN icon
1954
Lindsay Corp
LNN
$1.17B
$1.49M ﹤0.01%
18,071
+14,026
+347% +$1.17M
AERI
1955
DELISTED
Aerie Pharmaceuticals
AERI
$1.49M ﹤0.01%
+50,278
New +$1.94M
DOG
1956
ProShares Short Dow30
DOG
$86.9M
$1.49M ﹤0.01%
27,759
-457
-2% -$25K
SPSC icon
1957
SPS Commerce
SPSC
$2.69B
$1.49M ﹤0.01%
+29,066
New +$1.52M
FTSD icon
1958
Franklin Short Duration US Government ETF
FTSD
$308M
$1.48M ﹤0.01%
15,660
+3,854
+33% +$364K
NEWT icon
1959
NewtekOne
NEWT
$372M
$1.48M ﹤0.01%
64,480
-712
-1% -$15.5K
OIH icon
1960
VanEck Oil Services ETF
OIH
$1.95B
$1.48M ﹤0.01%
5,005
+184
+4% +$57.4K
MFA
1961
MFA Financial
MFA
$919M
$1.48M ﹤0.01%
51,359
-320
-0.6% -$9.34K
ESGR
1962
DELISTED
Enstar Group
ESGR
$1.47M ﹤0.01%
8,424
-8,028
-49% -$1.39M
NRK icon
1963
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$916M
$1.46M ﹤0.01%
111,794
-4,930
-4% -$63.7K
KE
1964
Kimball Electronics
KE
$605M
$1.46M ﹤0.01%
90,001
+3,087
+4% +$47.9K
CAC icon
1965
Camden National
CAC
$970M
$1.46M ﹤0.01%
31,795
-1,695
-5% -$74.1K
EVRI
1966
DELISTED
Everi Holdings
EVRI
$1.46M ﹤0.01%
122,137
+23,043
+23% +$250K
VWTR
1967
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$1.46M ﹤0.01%
125,386
+1,348
+1% +$14.9K
EDIT icon
1968
Editas Medicine
EDIT
$432M
$1.46M ﹤0.01%
58,848
+42,050
+250% +$1M
APA icon
1969
APA Corp
APA
$14.4B
$1.45M ﹤0.01%
50,108
-10,027
-17% -$312K
WERN icon
1970
Werner Enterprises
WERN
$2.2B
$1.45M ﹤0.01%
46,693
+29,103
+165% +$939K
BSCP
1971
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$1.45M ﹤0.01%
68,527
+33,834
+98% +$701K
MIE
1972
DELISTED
COHEN & STEERS MLP INCOME AND ENERGY OPPORTUNITY FUND, INC.
MIE
$1.45M ﹤0.01%
153,133
+6,700
+5% +$63.6K
CALM icon
1973
Cal-Maine
CALM
$3.85B
$1.45M ﹤0.01%
34,732
+12,687
+58% +$522K
RDFN
1974
DELISTED
Redfin
RDFN
$1.45M ﹤0.01%
80,542
-28,325
-26% -$543K
CBH
1975
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$1.45M ﹤0.01%
156,814
+27,486
+21% +$251K
77 78
79
80 81

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.